Left atrial dilatation and ST-T changes predict cardiovascular outcome in chronic hemodialysis patients

Kiyotsugu Omae1, Tetsuya Ogawa, Masao Yoshikawa

  • 1Department of Medicine, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo, 116-8567, Japan.

Heart and Vessels
|September 29, 2011
PubMed

Insights

for chronic hemodialysis patients, enlarged left atrium (LA) and ST-T changes on ECG predict cardiovascular events. Early detection aids in monitoring cardiovascular risk and improving patient outcomes.

Area of Science:

  • Cardiology
  • Nephrology
  • Diagnostic Imaging

Background:

  • The left atrium (LA) is sensitive to afterload, with reported volumetric remodeling.
  • Left atrial enlargement and ST-T changes are potential indicators of cardiovascular risk.

Purpose of the Study:

  • To prospectively examine the effects of LA enlargement and ST-T changes on cardiovascular outcomes in chronic hemodialysis (HD) patients.
  • To investigate the prognostic value of ST-T changes and LA dilatation for cardiovascular events in HD patients.

Main Methods:

  • Prospective study of 112 chronic HD patients with serial echocardiography over a mean of 2.1 years.
  • Evaluation of LA size, left ventricular mass index (LVMI), and other echocardiographic indices.
  • Analysis of ST-T changes on ECG and their association with cardiovascular events using Cox proportional hazard and Kaplan-Meier analyses.

Main Results:

  • HD patients with ST-T changes and LA dilatation showed higher LVDd, interventricular septum thickness, fractional shortening, and LVMI.
  • Left ventricular hypertrophy (LVH) and new cardiovascular events were more frequent in patients with both ST-T changes and LA dilatation (p = 0.0127).
  • Cox analysis identified coronary artery disease, ST-T changes, LA dilatation, and serum albumin as significant predictors of cardiovascular events (HRs: 3.898, 5.182, 0.185 respectively).
  • Kaplan-Meier analysis showed significantly fewer events in patients without ST-T changes and LA dilatation (p < 0.0001).

Conclusions:

  • ST-T changes and LA dilatation are significant predictors of cardiovascular outcomes in chronic HD patients.
  • Detecting ST-T changes on ECG and LA dilatation is valuable for cardiovascular risk monitoring in this population.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...